Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05788081
Title Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab. (TOP-FLOR)
Acronym TOP-FLOR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Grampians Health RECRUITING Ballarat Victoria Australia Details
Eastern Health NOT_YET_RECRUITING Box Hill Victoria 3128 Australia Details
University Hospital Geelong, Barwon Health RECRUITING Geelong Victoria Australia Details
Austin Health RECRUITING Heidelberg Victoria 3078 Australia Details
Fiona Stanley Hospital RECRUITING Perth Western Australia Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field